<SEC-DOCUMENT>0001193125-14-194605.txt : 20140512
<SEC-HEADER>0001193125-14-194605.hdr.sgml : 20140512
<ACCEPTANCE-DATETIME>20140512150959
ACCESSION NUMBER:		0001193125-14-194605
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20140512
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20140512
DATE AS OF CHANGE:		20140512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INNOSPEC INC.
		CENTRAL INDEX KEY:			0001054905
		STANDARD INDUSTRIAL CLASSIFICATION:	CHEMICALS & ALLIED PRODUCTS [2800]
		IRS NUMBER:				981081725
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13879
		FILM NUMBER:		14833138

	BUSINESS ADDRESS:	
		STREET 1:		8310 SOUTH VALLEY HIGHWAY
		STREET 2:		SUITE 350
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		303-566-0528

	MAIL ADDRESS:	
		STREET 1:		8310 SOUTH VALLEY HIGHWAY
		STREET 2:		SUITE 350
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OCTEL CORP
		DATE OF NAME CHANGE:	19980209
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d724315d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported):&nbsp;05/12/2014 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>INNOSPEC INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission
File Number:&nbsp;1-13879 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>98-0181725</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>8310 South Valley Highway, Suite 350, Englewood, CO 80112 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices, including zip code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>303-792-5554 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>8375 South Willow Street </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Littleton </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CO 80124
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address, if changed since last report) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;7.01.&nbsp;Regulation FD Disclosure </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Innospec Inc. announced through a press release dated May&nbsp;12, 2014 that its board of directors has authorized the company to repurchase up
to an aggregate of $20 million of its shares of common stock. As disclosed in the release, the repurchases are intended, among other things, to reduce effects of dilution on the company&#146;s shares from exercises of options and other equity based
awards. The full text of the press release is attached as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01.&nbsp;Financial Statements and Exhibits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>EX-99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release dated May 12, 2014, announcing authorization of up to $20 million for repurchases of shares of common stock of Innospec Inc.</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">INNOSPEC INC.</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: May&nbsp;12, 2014</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/&nbsp;David E. Williams</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David E. Williams</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">VP, General Counsel, CCO and Corporate Secretary</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.10pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>EX-99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release dated May 12, 2014, announcing authorization of up to $20 million for repurchases of shares of common stock of Innospec Inc.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d724315dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g724315g55z45.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRESS RELEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INNOSPEC ANNOUNCES SHARE REPURCHASE PROGRAM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Englewood, CO &#150; May 12, 2014 &#150; </B>Innospec Inc. (NASDAQ: IOSP) today announced that its board of directors has authorized the Company to
repurchase up to an aggregate of $20 million of its shares of common stock. These purchases may be made from time to time, at the discretion of the Company&#146;s officers, on the open market or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Patrick S. Williams, President and Chief Executive Officer, said: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Our capital management program has always been designed to ensure that there is a good balance between the reinvestment of cash to grow our business
through acquisition or capital expenditure, and the return of cash to shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Having instituted a regular dividend, we believe the time is right to
also launch a buy-back program to, among other things, reduce the effects of dilution on shareholders&#146; equity from options and other equity based awards.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Innospec Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Innospec Inc. is an international
specialty chemicals company with approximately 1100 employees in 20 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. The Fuel Specialties
business specializes in manufacturing and supplying the fuel additives that help improve fuel efficiency, boost engine performance and reduce harmful emissions. This business also contains Oilfield Specialties which provides specialty chemicals for
oil&nbsp;&amp; gas drilling and production operations. Innospec&#146;s Performance Chemicals business provides effective technology-based solutions for our customers&#146; processes or products focused in the Personal Care; Polymers; and Fragrance
Ingredients markets. Innospec&#146;s Octane Additives business is the world&#146;s only producer of tetra ethyl lead. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains certain &#147;forward-looking statements&#148; within the meaning of the Private Securities Litigation Reform Act of 1995. All
statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like &#147;expects,&#148; &#147;estimates,&#148;
&#147;anticipates,&#148; &#147;may,&#148; &#147;believes&#148; or similar words or expressions), for example, which relate to operating performance, events or developments that we expect or anticipate will or may occur in the future (including,
without limitation, any of the Company&#146;s guidance in respect of sales, gross margins, pension liabilities and charges, net income, growth potential and other measures of financial performance) statements regarding shareholder value. Although
forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements.
Additional information regarding risks, uncertainties and assumptions relating to the Company and affecting our business operations and prospects are described in the Company&#146;s Annual Report on Form 10-K for the year ended December&nbsp;31,
2013, and other reports filed with the U.S. Securities and Exchange Commission. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading &#147;Risk
Factors&#148; in such reports. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brian Watt </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Innospec Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+44-151-356-6241 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brian.Watt@innospecinc.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert D. Ferris </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RF|Binder Partners </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1-212-994-7505 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert.Ferris@RFBinder.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dan Scorpio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RF|Binder Partners </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1-212-994-7609 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dan.Scorpio@RFBinder.com </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g724315g55z45.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g724315g55z45.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"``U`/`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#SO5+KQ6?&
M#/=R7HUE9R$"EMRMNZ)_LYZ8XKZCL3<&PMS=@"X,2^:!TWX&?US7EEW\=--M
MM1EB?P[*\D$C1B3SESP<<<5ZM!+YT$<H&-ZAL>F10!)17G/C?XO:?X8O!I^F
MP)J5XC?O_P!YM2+VR,Y;V[4GA;XSZ)KMU'9:A"VEW$A"HTCAHF/INXQ^(_&@
M#T>BDKFO&GCK2_!EAYMTPFNY!^XM4/S/[GT7WH`Z:BO(='^/EG-.L>L:0]LC
M'!EMY/,"^Y4@'\J]5T_4+/5;&*]L+A+BWF&Y)$.010!9HK)\0^)M)\+:?]MU
M:Z$,9.$4#+R'T4=Z\OOOV@`)B-/T'=$#PT\^&/X`''YT`>S45YCX=^.&BZG<
M);:M:OICN<"4OYD6?<X!'Y5Z8CK(BNC!D895E.01ZB@!U%>9^*_C5I>AW\MA
MI=F=2FA8K))YFR,,.H!P2:S='^/EI/<+'K&D/:QL<>=!)Y@7W*D`_E0!Z]14
M%E>VVI645[9S+/;S*&CD0\,*X_QY\3=.\&J+6)%OM2;!^SA\"-?5SV]AUH`[
M>BO*]"^.VDWLZ0:QI\NG[CCSD;S4'UX!'Y&O3[:Y@O+:.YMI4FAE4,DB'*L#
MW!H`EHK+U_Q'I7AG3C?:K=+!%T4=6<^BCN:\OU#X_HLY73M!+Q`\/<3[2?P`
M./SH`]DHKS3PO\;-'UF[CL]4MFTN:0[4D+[XB?0G`(_'BO2@<C(H`6BN,\7_
M`!0T'PE,UHY>]OEZV\!'R?[S=!].3[5PZ_M`S^?\WAZ/R<]!<G=C_OG%`'M=
M8^M^)+/0;FUCO5<1W.X>8HR$QCJ/QK-\(?$30_&68;-W@O%7<]K,,-CN01P1
M6/\`%/IIW_;3^E9U9.,&T=F!HQKXB-.>SO\`D=Y;74%Y`L]M,DT3C*NAR#4U
M>3^'-,\2:?MO;:YBT^&3G%T^%D'^YU_&O2=,OGO(/WS6YF4?-Y$FY3],\BHI
MUXR?*]&/%X6-"=H34E^)?HI,TM;G$?(&K_\`(<OO^OF3_P!"->Y_%CQ)J>@>
M#--BTR?[.U]B*25?OA0@.%/;/K7AFK_\AR^_Z^9/_0C7KWQQ_P"14T#_`*Z'
M_P!`%`%?X%Z;8:E9ZT;ZRM[HB2,`SQ*Y&0V>HKG/B_X3T_PQXAMY-,C$-M?1
ME_)'2-@<''L<CCZUUG[/W_'EK7_72+^350_:!_Y"6B_]<9?YK0!T?@OQ??R?
M!V\U,L);W28Y8E:3G=M4%2?7@@?A7FW@&[F\1?%*QN=987TD[N9//`8'Y&P,
M'C`["NG\!_\`)#_$_P#O3?\`HI*Y'X3_`/)2-*_WI/\`T!J`/1?C#X(T>/PU
M)KMA9PV=U:NN_P`E0BRJ2!R!QD9!S6)\!]>GCU:]T*20M;2Q&XC4GA'4@''U
M!_2N^^+G_)-]3_[9_P#H:UY5\$5W>/&7ULI1^JT`87CSQ'=>+/%]S.69H4D,
M%K'GA4!P,>YZGZU[7X6^%/AS2-'A34=.AU"^=`9Y9UW`,1R%!X`'YUX!?P3:
M'XGFAN(R)+*[.Y3WVM_6OK'3[^WU33[>_M)%D@N(Q(C*<Y!H`\,^+WP^L/#:
MV^LZ/$8+6>3RIH,DJCXR"N>QP>*V/A)XDU#4?">L>'Q(SW-G;,]D<\@$$;1]
M&QCZUH_'?5K>'PU::5O4W-Q<"4)GD(H//YD#\ZP?@#I\S:MJFI;2(8X%AW=B
MS-G^2_K0!YGHUU:Z=KMK<ZG9?;+:&4--;L<;P.H->YVMA\,OB);I'9V]M!<C
M!\N)1;SKCM@?>'YU)XO^$FC>*I9=2TNY6QO9"=[1@-%(V><@=#GJ1^5>+^)/
M"VM^"=4CBOU\IS\\%Q"_ROCNIZ@C\Z`/H'Q[J<WA#X?W,^BI';O;K'#"`O$8
M+!>!Z@&O)O@Y!#K7CFZ;5(DOB]J[L;E1)EMR\\]^:VM0\3W?BCX#W<]^WF75
MM<QP22'K)AU(8^^#S]*R?@3_`,CO<?\`7D__`*$M`&[\6_AQIMEI#^(=$M5M
M6@8?:8(QA&4G&X#L02.E4_@;XJGBU.7PS<R%K>9&EM@3]QQRP'L1D_4>]>@_
M%74K;3OA]J2SN`]T@@B4]68D=/H,G\*\:^#UI+=?$6Q>,';;I)+(1V7:1_,@
M4`4OB-XFN/$WB^[D:0FVMI&@MDSPJ@XS]21FO4?"/@WP!I.C0?VI=:3?W\B!
MIWGN48*2/NJ"<`#IZUXMXBT^72_$FH6-PI#PW+J?<9X/XC!KU72O@EH6L:7;
M:C:>(+IX;F,.I$:=^WU'2@#E/BIX=\/Z/J5M>>'+NV>VNPPD@@G$@B<8Z8)P
M#G]#79>'OB#<VGP8NKYY"]_I[?8XG;DDG&PGUP#_`..TY_@'I$:[GU^Z5>F6
MC0"H_%?PX3PM\+]4M["[FO!]ICNGWJ`0%^4]/8Y_"@#SOP+X:?QOXN2SNII/
M*.Z>ZESEBHZ\^I)`S[U[\GPX\'):BV_X1^S*`8W,F7/_``+K^M>-_!35;?3O
M''D7#J@O;=H8V8X&_(('XX(KZ*H`YKPQX"T/PC?7EWI<4BO=`#$C;O+4?PJ>
MN"?7T%2>)+"&:ZM=0N8Q)%8H[JC=&D)`7/MW_"N@R,XK'\0NLMN;$?ZZ1#*@
M_O;",C\C6&)YE1DX[I,TISE"5X[G)3SRW,K2S.7=NI-)%+)!(LD3E'4Y#"FT
M5^?<TN;FOJ,M:GXGO]!FM-0A`FLKP$2VSGA)%ZE3VSG..E=/H7B?3/$$?^B2
M[9E&7@?AU_Q'N*X/Q3#-/9Z5I-O"\UW(7G,:#)`.`OTZ&M;PM\/7M)X[_5I2
M)4^9((G(VG_:8?R%?J&'C">!IU*SM-K[SR54JK$2A!7C^1X_J?@#Q=-J]W+'
MX?O61[AV5A'U!8\UZ=\7?#^KZUX<T6WTS3Y[J6%R9$B7)3Y`.:]&74(&@EG&
M_P`N(\MMZ_2E^W0B*21MR>60&5EP>>G'O7'[6'<]$\X^"OA_5]!M=635M/GL
MS*\9C$JXW8#9Q^=5/C5X:UK7K_2GTG39[Q88I!(8ESM)*XS^5>HB_A,(D7<<
MML"`?-N],5()\SF/IB,/C'/6FJD7LP/*O!WAO6K'X1^(=+NM,N(;VX:7R8&7
M#/F-0,#Z@US/PV\&>)=*\>:;>W^BW=O;QE]\KIA5RC#G\:]T?4$-K-+$#NBP
M"K"I?M7^EO;^4_R(&W8X/^<5/M8/K_7](#G/B9IUYJO@._LM/MI+FXD\O;%&
M,L<."?TKSKX1>$O$&B^-#=ZGI%S:P?99%\R1,#)*X%>U0W,4YQ&2?D#=.QZ4
M&X3[1Y`#,V,M@<+Z9-7SQM>X'GOQ*^%H\52?VMI+I#J84"1'X2<#ID]F'3->
M86L?Q(\&A[*T@U:TC))V1PF2,GU'!'Y5]%VM\L[;'5E<E@#M^4[3C@TZ+4+>
M8OL8_(I;IU`[BH5:FTG?<#YYTWX>>-?&>J?:]4BN8%D(\R[O\@X]E/)^G2O<
M-+\)P:#X2?0M&N'M':)@+O:&?S".7(]?Y5J)J4#L%"RC)7DH0!NZ?G3S=HGG
M%SD1N%`4'))`P/<\T*M!JZ8'@4F@?$KP#<RC36O);=F+&2T!FC?W*X.#]169
M=:7\0/'FHQ&^L;^Y=/E1IX?*CC!Z]0`*^D9KR.WB665753UX^[]:1[L1SRA\
M"..(2$CKU/\`A3=6"TN!Y;XI\*KX/^"%QIAD$LYFCDGD'1G+KG'L,`?A7EG@
M_4_$.DZK)=>&X9);H0D.L<'FG9D9XP>^*]R^+T@E^&5[(`0&DB(!Z_?%><_`
MG_D=[C_KR?\`]"6K3NKH#)N]+^(/CW4D:]L;^X<'"F:(Q11`^F0`*]F^'7@"
M'P5IKF619]1N0//E4<*!T1?;W[UV5%,#SSXD_#!/%I&IZ8Z0:HB[6#\).!T!
M/8CUKRNUM_B1X++VEG;ZK:1LV2L41EC)]1@%?RKZ7HH`^=(?#7Q)\<7$8U`W
MZP@@^9?,8HT]POK]!7OFGV$T6AP6&IW`OY5@$4\K)@3<8.1[U?HH`\$\9_!O
M5M,O7O?#4;7EF6W+"K?O8?8?WAZ8YK)BUSXJ(BV$;:Y\ORA3;,6_[ZVY_6OI
M&B@#R[X4^'/&6E:C>:CKSLEO>(-\5S*7F=QT;J<=QSZUJ_$F[GL+K2;JVD,<
MT3.RL.W2N\KD?&WAV^\0W&GQ6@54CWF25S@(#C\ZTIM*6IOAW%5$Y;'.6_B;
M1M0`:]2:PN3]XPIYD;GU`ZCZ5UNCZ'9S*MTXG=>J+-'Y8/OMZ_G3M`\%Z9H8
M679]INAUFD'3_=':NAKAG@,&ZG/&&O\`70*TJ=_W9!;V-M;2R31QCS93F20\
MLWX^GM5BBBNJ]SG22V,ZZLTBM+IP[%I5`).!W]OK4YL(FBD21G<R$%F8\\=/
MRHHKG5*'.U;I_F4*;-#$B;V#(VY7&`0?RQ3FM4<L6+$O'Y9.>W^/-%%:>SCV
M$1IIT*0R1[G(EQN/`Z=.@J5H0LYN`S!MFTKV('2BBCV<(K1`5]*5?LAF48\Y
MR^/[O/2K'V<?://5V5B`&`Z-CIFBBHHQ3I1&(EI&AC(W?NRQ&3_>ZTR&PBA1
MT0ML92N..`??&:**OV4.PA?L,7JW\'?^[TI7LXW$@)8&1P^0>01C!'Y444>S
MAV`9/I\=R%$LDA(4J3QR#U[5*;==[.&8,R!,^P__`%T44>R@G>P&9K7A>PU[
M0)-$O&F%M(P9C&P5LAMW7'K[5E>%OAKH7A'4WU'37NVF>(Q$32!A@D'H`/2B
EBK225D!UU%%%,`HHHH`****`"BBB@`HHHH`****`"BBB@#__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
